Supplementary Table 2 from Metabolic Syndrome and Risks of Breast Cancer Outcomes for Luminal, Triple-Negative, and HER2-Overexpressing Subtypes

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Supplementary Table 2 presents results for breast cancer recurrence associated with metabolic syndrome and its components by molecular subtype of breast cancer and stratified by age at diagnosis.